These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 18922852)

  • 1. Anti-CD3 preconditioning separates GVL from GVHD via modulating host dendritic cell and donor T-cell migration in recipients conditioned with TBI.
    Li N; Chen Y; He W; Yi T; Zhao D; Zhang C; Lin CL; Todorov I; Kandeel F; Forman S; Zeng D
    Blood; 2009 Jan; 113(4):953-62. PubMed ID: 18922852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of host CCR7(+) dendritic cells prevented donor T cell tissue tropism in anti-CD3-conditioned recipients.
    He W; Racine JJ; Johnston HF; Li X; Li N; Cassady K; Liu C; Deng R; Martin P; Forman S; Zeng D
    Biol Blood Marrow Transplant; 2014 Jul; 20(7):920-8. PubMed ID: 24691220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor CD8+ T cells mediate graft-versus-leukemia activity without clinical signs of graft-versus-host disease in recipients conditioned with anti-CD3 monoclonal antibody.
    Zhang C; Lou J; Li N; Todorov I; Lin CL; Cao YA; Contag CH; Kandeel F; Forman S; Zeng D
    J Immunol; 2007 Jan; 178(2):838-50. PubMed ID: 17202345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bendamustine with total body irradiation conditioning yields tolerant T-cells while preserving T-cell-dependent graft-versus-leukemia.
    Stokes J; Hoffman EA; Molina MS; Kummet N; Simpson RJ; Zeng Y; Katsanis E
    Oncoimmunology; 2020; 9(1):1758011. PubMed ID: 32391190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDAC inhibitor reduces cytokine storm and facilitates induction of chimerism that reverses lupus in anti-CD3 conditioning regimen.
    Li N; Zhao D; Kirschbaum M; Zhang C; Lin CL; Todorov I; Kandeel F; Forman S; Zeng D
    Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4796-801. PubMed ID: 18347343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flt-3L Expansion of Recipient CD8α
    Markey KA; Kuns RD; Browne DJ; Gartlan KH; Robb RJ; Martins JP; Henden AS; Minnie SA; Cheong M; Koyama M; Smyth MJ; Steptoe RJ; Belz GT; Brocker T; Degli-Esposti MA; Lane SW; Hill GR
    Clin Cancer Res; 2018 Apr; 24(7):1604-1616. PubMed ID: 29367429
    [No Abstract]   [Full Text] [Related]  

  • 7. Enrichment of IL-12-producing plasmacytoid dendritic cells in donor bone marrow grafts enhances graft-versus-leukemia activity in allogeneic hematopoietic stem cell transplantation.
    Darlak KA; Wang Y; Li JM; Harris WA; Owens LM; Waller EK
    Biol Blood Marrow Transplant; 2013 Sep; 19(9):1331-9. PubMed ID: 23810844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programming of donor T cells using allogeneic δ-like ligand 4-positive dendritic cells to reduce GVHD in mice.
    Mochizuki K; Meng L; Mochizuki I; Tong Q; He S; Liu Y; Purushe J; Fung H; Zaidi MR; Zhang Y; Reshef R; Blazar BR; Yagita H; Mineishi S; Zhang Y
    Blood; 2016 Jun; 127(25):3270-80. PubMed ID: 27143255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation and host retinoic acid signaling promote the induction of gut-homing donor T cells after allogeneic hematopoietic stem cell transplantation.
    Zheng J; Taylor B; Dodge J; Stephans A; Zheng SG; Chen Q; Chen X
    Am J Transplant; 2020 Jan; 20(1):64-74. PubMed ID: 31207088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice.
    Asakura S; Hashimoto D; Takashima S; Sugiyama H; Maeda Y; Akashi K; Tanimoto M; Teshima T
    J Clin Invest; 2010 Jul; 120(7):2370-8. PubMed ID: 20530875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bendamustine Conditioning Skews Murine Host DCs Toward Pre-cDC1s and Reduces GvHD Independently of Batf3.
    Molina MS; Stokes J; Hoffman EA; Eremija J; Zeng Y; Simpson RJ; Katsanis E
    Front Immunol; 2020; 11():1410. PubMed ID: 32765499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor Immunity.
    Betts BC; Locke FL; Sagatys EM; Pidala J; Walton K; Menges M; Reff J; Saha A; Djeu JY; Kiluk JV; Lee MC; Kim J; Kang CW; Tang CH; Frieling J; Lynch CC; List A; Rodriguez PC; Blazar BR; Conejo-Garcia JR; Del Valle JR; Hu CC; Anasetti C
    Front Immunol; 2018; 9():2887. PubMed ID: 30574153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
    Pelot MR; Pearson DA; Swenson K; Zhao G; Sachs J; Yang YG; Sykes M
    Biol Blood Marrow Transplant; 1999; 5(3):133-43. PubMed ID: 10392959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch inhibition enhances graft-versus-leukemia while reducing graft-versus-host disease.
    Luo X; Xu L; Liu L; Li Y; Tan H
    Eur J Pharmacol; 2019 Jan; 843():226-232. PubMed ID: 30445020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells.
    Zhang J; Chen HM; Ma G; Zhou Z; Raulet D; Rivera AL; Chen SH; Pan PY
    Leukemia; 2019 Aug; 33(8):2078-2089. PubMed ID: 30737483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity.
    Lu Y; Giver CR; Sharma A; Li JM; Darlak KA; Owens LM; Roback JD; Galipeau J; Waller EK
    Blood; 2012 Jan; 119(4):1075-85. PubMed ID: 22130799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ikaros deficiency in host hematopoietic cells separates GVL from GVHD after experimental allogeneic hematopoietic cell transplantation.
    Toubai T; Guoqing H; Rossi C; Mathewson N; Oravecz-Wilson K; Cummings E; Wu J; Sun Y; Choi S; Reddy P
    Oncoimmunology; 2015 Jul; 4(7):e1016699. PubMed ID: 26140241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Effect of MyD88 Signal in Donor T Cells on Graft-versus-Leukemia Effect and Graft-versus-Host Disease after Experimental Allogeneic Stem Cell Transplantation.
    Lim JY; Ryu DB; Lee SE; Park G; Choi EY; Min CK
    Mol Cells; 2015 Nov; 38(11):966-74. PubMed ID: 26552489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daratumumab Prevents Experimental Xenogeneic Graft-Versus-Host Disease by Skewing Proportions of T Cell Functional Subsets and Inhibiting T Cell Activation and Migration.
    Gao Y; Shan W; Gu T; Zhang J; Wu Y; Li X; Zeng X; Zhou H; Chen Z; Xiao H
    Front Immunol; 2021; 12():785774. PubMed ID: 34987512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.